EVO-NANO Evolvable platform for programmable nanoparticle-based cancer therapies

Dra. Isabel Rodríguez

Funding :

European Commission H2020-FETOPEN-2016-2017 no 800983

Duration: 2018 - 2022

EVO-NANO aims to create an integrated cross-disciplinary platform for the artificial evolution and assessment of nanoparticle-based drug delivery systems.